Blood cancer Clinical Trials in Birmingham, AL

As of July 2026, 44 paid clinical trials are recruiting for Blood cancer in Birmingham, Alabama. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

44 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

Conditions in Blood cancer (Birmingham, AL)

Multiple myeloma· 12Acute myeloid leukemia (AML)· 10Non-Hodgkin lymphoma· 8Hematologic malignancy· 8Myelodysplastic syndromes (MDS)· 7Leukemia (other)· 5Myelofibrosis· 5Follicular lymphoma· 3Mantle cell lymphoma· 3Chronic lymphocytic leukemia (CLL)· 2Myeloproliferative neoplasm· 2Hodgkin lymphoma· 2Marginal zone lymphoma· 2Small lymphocytic lymphoma· 2Chronic myelomonocytic leukemia· 1Acute lymphoblastic leukemia· 1Diffuse large B-cell lymphoma (DLBCL)· 1